Professor of Cardiology, University of Milano-Bicocca; Scientific Director and Head of Cardiovascular Dept. Ist. Auxologico Italiano, IRCCS, Milan, Italy.
@drjkahn the "nature" paper is not a validation study. The paper is published in "Communication Medicine" (open access journal, Nature group).It reports on use of this device at the time of covid-19 vaccination, without any prove of accuracy of reported data
https://t.co/kDSdSR2WNf
@drjkahn Validated by means of which international protocol?
Would you be so kind as to share the link to the paper?
This device does not appear in any internationally acknowledged list of Validated BP monitors...
@RwandaMedicalAs It was a pleasure to partecipate in the RCP Symposium in Kigali and to learn about the excellent work which is being implementare for CV prevenzione in Rwanda
We congratulate Prof. Charlotte Bavuma; Chair of Rwanda College of Physicians for a very significant Hypertension Symposium 2022 & General Assembly; a scientific gathering that opens the door for more opportunities for collaboration between doctors in Rwanda 🇷🇼 & Italy 🇮🇹
@TwittAuxologico Grande professionalità, sempre disponibile a collaborare nelle attività della nostra Cardiologia e entusiasmo nella ricerca.
Grazie Valeria!
@Hragy@NakagawaPablo@HyperAHA#hyphip we did not test the Arteriograph device, as it was not available for our study. In theory it should work with a different method as compared to algorithmic devices
@DrDudenbostel @ATCOR @NakagawaPablo@HyperAHA#hyphip we did not use the XCEL device ourselves.
There are published data suggesting that it might be as accurate as the previous version.
@Hragy@NakagawaPablo@HyperAHA#hyphip there are several solutions to improve tonometric assessment of PWV and to make it easier ( e.g. mechanical arms to help with the probe). And some tonometric devices are now also cheap enough.
@guto_montezano@HyperAHA@NakagawaPablo#hyphip Moreover, devices including muscle arteries in the assessment of PWV do not provide a reliable assessment of AORTIC PWV, i.e. of the parameter known to have the highest prognostic value.
@guto_montezano@HyperAHA@NakagawaPablo#HYPHIP Thank you for this important question @guto_montezano. Devices based on algorithms do not measure PWV but only estimate it based on age and brachial SBP. Thus they cannot pick up changes due to vascular damage (e.g. Marfan Syndrome)
@fjorios@HyperAHA#HYPHIP the stronger relationship with age of invasive aortic PWV as compared with that of noninvasive cf-PWV could be justified by the higher arterial muscular component in the arterial path considered by cf-PWV which is not modified by age
@fjorios@HyperAHA#HYPHIP. Thank you @fjorios for your comment.
Indeed in younger subjects we found that all non-invasive methods overestimate intra-arterial measurements
@DrDudenbostel@NakagawaPablo@HyperAHA#HYPHIP PWV assessment cannot generate information on central BP. Carotid-femoral PWV has an established prognostic value. Conversely, the prognostic role of central BP still remains to be better clarified